Hims is officially phasing out its copycat weight-loss drugs, and the company's stock tumbled — again
After the FDA removed semaglutide injection products from a shortage list, compounders like Hims have 60-90 days to stop making copies.
Pharmaceuticals
New weight-loss drugs like Mounjaro are hot right now. Eli Lilly's CEO explains why they're so expensive.
David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous value they offer.
Expect AI-made prescription drugs to be ready for clinical trials in a couple of years, predicts Google DeepMind CEO
"I think we are very close," Google Deepmind's CEO said when asked if AI could help cure a major disease like Alzheimer's or cancer.
Pharma giants are hiking prices on over 500 drugs for 2024, report says
Pfizer, Sanofi, and Takeda Pharmaceutical are set to increase prices on more than 500 drugs in the US next year.
Ozempic maker Novo Nordisk isn't just Europe's 2nd-most-valuable company. It's also single-handedly boosting Denmark's economy.
"If it wasn't for Novo Nordisk there wouldn't have been any growth in the first six months of the year," the chief economist at Danske Bank told AFP.
Warren Buffett and Vivek Ramaswamy are miles apart politically. But the investing icon and Republican upstart have these 3 things in common.
Buffett and Ramaswamy are both bargain hunters with a taste for holding companies, who worry about the clash between business and social issues.
Ketamine is being sold as a depression wonder drug. For some, it's making everything worse.
Ketamine therapy is a revolutionary new depression treatment. But as multimillion-dollar investments pour in, some people find they can't stop.
Novartis' CEO is charging ahead in cutting tens of thousands of workers to transform the $220 billion pharma giant
Vasant Narasimhan, the CEO of Novartis, told Insider he expected to cut the pharma giant's headcount by about 30% through layoffs and spinoffs.
A tiny biotech's experimental treatment for a silent disease that strikes millions just cleared a key hurdle and the stock is up more than 200%
Madrigal Pharmaceuticals reported positive results for its treatment for NASH. It hopes to file for FDA approval in 2023.
Gambia offered $285 to the families of 70 children whose deaths have been linked to contaminated cough syrup. The families say the offer is 'an insult to the victims.'
Ebrima Sanyang, the chairperson of the grieving families, told BBC that the money was "an insult to the victims."
Ferring Pharmaceuticals has suspended shipments of a key fertility drug, Menopur
Ferring Pharmaceutical is "working to address any disruptions to supply," the company said in a memo sent to healthcare providers.
Meet the rising stars of Wall Street who are navigating volatile markets and transforming the industry while still in their 20s and 30s
We pinpointed the young finance professionals on the runway to success, even as banks and money managers brace for cutbacks.
2 reasons why China is still in lockdowns, more than 2 years after the pandemic started — and what it'll take for life to go back to normal
China's zero-Covid policy is not just about national pride and safety in the COVID-19 pandemic. It's also about the next pandemic.
'Pharma bro' Martin Shkreli - now free from prison - has launched a crypto business aimed at disrupting the pharmaceutical drug industry
Shkreli told The Milk Road he's "aghast" at the high price tag of drug-discovery software and squeezing prices "almost to zero is my dream."
Viagra users may have a lower risk of Alzheimer's disease, study finds
A review of data from more than 7 million people showed those who were prescribed sildenafil were 69% less likely to develop Alzheimer's disease.
Warren Buffett's Berkshire Hathaway reveals new bets on Floor & Decor and Royalty Pharma
The famed investor's company also exited Merck and trimmed several holdings including Visa, Mastercard, and AbbVie.
Kyrsten Sinema takes thousands in campaign contributions from pharmaceutical giants while stalling prescription drug pricing reforms
Since the start of her political career, pharmaceutical companies have lobbied Sinema and financed her campaign committee and leadership PAC.
Warren Buffett's Berkshire Hathaway is betting on private tech, stands to profit from Biden's $1 trillion infrastructure plan, and could be eyeing Chinese stocks. Veteran investor Darren Pollock explains why.
Buffett's company struck pre-IPO deals with Snowflake and Nubank, has sprawling infrastructure interests, and might capitalize on the China tech rout.
Warren Buffett's Berkshire Hathaway sold Biogen, halved its Merck stake, and boosted its Kroger bet. Here's a closer look at its key trades in Q2.
Buffett's company established stakes in Merck, AbbVie, and Bristol Myers Squibb in the second half of last year, yet it slashed all three positions.
Here are the 20 fastest growing biotech and pharma companies that pay people the most
Novavax, BioCryst, and Zogenix are among the biotech firms with lucrative pay packages.